Pilot & Feasibility
Protocols & Methods
Reagents & Resources
Tissues & Samples
IMPC / KOMP Data
Pilot & Feasibility
Florida International University
Validation of Tissue Oxygenation Biomarker to Assess Healing of Diabetic Foot Ulcers using a Low-Cost Hand-Held Optical Imager
Of the nearly 29.1 million people diagnosed with Diabetes Mellitus (DM) in the USA, up to 25% develop diabetic foot ulcers (DFUs). Diabetic wounds become chronic for a variety of reasons including a suboptimal inflammatory phase of wound healing. An obstacle to development of therapies is the availability of validated biomarkers to assess healing, infection, and/or risk for recurrence. The clinical standard of assessing healing is from visual assessment of wound color, degree of epithelization, and size reduction across weeks of treatment. Oxygenation and blood flow to wound site has been measured using Doppler ultrasound (DUS), transcutaneous oxygen measurements (TCOM), hyperspectral imaging (HSI), or near-infrared spectroscopy (NIRS). While all these imaging tools have been applied in studies of DFUs, most have been limited to TO changes away from the wound (as blood flow by DUS) or at discrete points around the wound (as in TCOM and NIRS). Additionally, HSI used visible wavelengths, limiting its ability to image below the intact skin surface. There has been no validated TO-based biomarker developed to date to assess healing (subcutaneously) at the wound site during treatment. Use of NIR wavelengths allows subcutaneous imaging, unlike visible wavelengths used in HSI for surface imaging of wounds. At Optical Imaging Laboratory, we have developed a low-cost hand-held wide-field NIRS system to subcutaneously measure TO of the wound area. Our pilot studies demonstrated detection of subcutaneous TO changes at the wound site and longitudinally across weeks of care and healing. Herein, the objective is to validate and establish a TO-based biomarker for subcutaneous assessment of healing in DFUs via controlled phantom studies and longitudinal in-vivo studies across weeks of treatment. Our specific aims include: (i) Validate and calibrate the low-cost near-infrared optical scanner to measure TO changes, via controlled phantom studies;(ii) Develop a quantifiable TO biomarker for assessing healing of 10 DFUs via longitudinal studies across 4-weeks of treatment. The proposed work is innovative in obtaining subcutaneous TO maps using a low-cost, hand-held near-infrared optical scanner (NIROS) using only a few discrete wavelengths (unlike HSI), and also perform real-time non-contact imaging. The proposed study can eventually impact DFU wound care by allowing clinicians to personalize treatment plan so as to minimize TO reduction-mediated failure of healing.
No funding program application progress reports found.
No uploaded documents found.
No publications found.
No uploaded documents found.
No protocols found.
The DiaComp Steering Committee is the governing body of the consortium. The principle function of this committee is to guide the scientific direction of the consortium. This is accomplished by creating various subcommittees necessary to advance the scientific goals and providing guidance to the broader complications research community. Policies for the consortium are developed through consultation with the
External Evaluation Committee
The DiaComp Wound Healing Committee has the principal function of furthering the mission of the consortium with regard to diabetic wound healing.
Curation Flag Information
New comment to be added:
No experiments found.
No strains found.
No models found.
Welcome to the DiaComp Login / Account Request Page.
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an external advisor to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
There was a problem with the page:
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
© 2018 DiaComp.org
All rights reserved
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!